A cyclopropyl-containing amide compound, its preparation method and application
By developing cyclopropyl-containing amide compounds, the problem of pesticide tolerance defects in pests has been solved, providing an effective means of fungal control, especially with significant inhibitory effects on rice sheath blight, tomato gray mold, and wheat scab.
Patent Information
- Application Number
- CN202611159663.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-02
- Publication Date
- 2026-11-17
AI Technical Summary
The intolerance of pests to pesticides makes it difficult to effectively control them with existing insecticides and fungicides. Furthermore, the resistance mechanisms are complex, and single control strategies are difficult to maintain for a long time. In particular, fungal diseases develop rapidly, making control measures difficult.
To develop a cyclopropyl-containing amide compound, and to introduce cyclopropylamine fragments through an active substructure splicing method to form a novel amide derivative for use in agricultural pest control to inhibit or kill harmful fungi.
This compound exhibits significant inhibitory activity against fungi such as rice sheath blight, tomato gray mold, and wheat scab. The compound is easy to prepare, uses readily available raw materials, has easily controllable reaction conditions, and has a high yield, making it suitable for use as a pesticide fungicide.
Smart Images

Figure SMS_5 
Figure SMS_7 
Figure SMS_8
Abstract
Description
Technical Field
[0001] This invention belongs to the field of pesticide technology, specifically relating to an amide compound containing cyclopropyl groups, its preparation method, and its application. Background Technology
[0002] The deficiency in pesticide tolerance among pests poses a serious challenge to agricultural ecological security and public health, essentially a necessary result of adaptive evolution under the pressure of chemical selection. This deficiency is not simply physiological inertia, but a complex complex comprised of multiple mechanisms, including target resistance, metabolic resistance, behavioral resistance, and impaired epidermal penetration. Reduced target sensitivity stems from point mutations in genes, preventing pesticide molecules from effectively binding to their sites of action; for example, the KDR mutation in insect sodium ion channels renders pyrethroid pesticides ineffective. Metabolic resistance relies on the overexpression or enhanced activity of detoxification enzymes such as cytochrome P450, esterases, and glutathione S-transferase. These enzymes rapidly catalyze the oxidation, hydrolysis, or binding reactions of pesticide molecules, significantly reducing their effective concentration. Alarmingly, these tolerance mechanisms often exhibit cross-resistance characteristics, meaning that the adaptation mechanism developed to one class of pesticides can simultaneously weaken the effects of other pesticides with similar structures or pathways of action. More challengingly, tolerance defects exist in the population as recessive or dominant alleles. Sustained exposure to sublethal doses accelerates the accumulation of resistance gene frequencies, and genetic linkage effects can couple these genes with life history traits such as fertility and developmental rate, giving resistant individuals a relative advantage in field competition. Currently, while resistance monitoring technologies have developed methods combining molecular marker detection and bioassays, the dynamic nature of resistance succession, the uneven geographical distribution, and the synergistic effects of multiple resistance mechanisms make it difficult for any single control strategy to be effective in the long term.
[0003] Regarding the long-term use of insecticides and fungicides, some pests have developed resistance to pesticides, making them difficult to eliminate using conventional insecticides and fungicides. Furthermore, some fungal diseases are numerous, develop rapidly, and are difficult to control, thus seriously hindering the development of agriculture in my country. Therefore, there has long been a desire to develop new, highly effective, and low-toxicity fungicides. Summary of the Invention
[0004] The purpose of this invention is to provide an amide compound containing cyclopropyl groups, its preparation method, and its application.
[0005] An amide compound containing a cyclopropyl group, the structural formula of which is shown in formula (I), ; R is selected from CH3, C2H5, i-C3H7, c-C3H 5、One of CH2CH(CH3)2; A is selected from one of the following rings: pyrazole, thiazole, pyridine, pyrimidine, oxazole, thiophene, benzene ring, etc.; Ar is selected from one of the following rings: benzene ring, pyridine ring, thiazole ring.
[0006] R is one of CH3 or CH2CH3; A is selected from one of pyrazole, pyridine, or benzene ring.
[0007] The A is selected from A1-A9; A1-A9 are shown below: ; Where R 1 Selected from one of CH3, C2H5, CH2=CH2, i-C3H7, c-C3H5, -CH2CF3, -CH2CH(CH3)2, -CH2CH(CH2)2, Ph, 4-Cl-Ph; R 2 Selected from one of H, CH3, C2H5, i-C3H7, c-C3H5, CF3, CHF2, -CH2CH(CH3)2, -C(CH3)3; R 3 Selected from one of H, Cl, Br; R 4 Selected from CH3 and CF3; R 5 Selected from one of OCH3 and OCH2CH3; R 6 Selected from one of CH3, CF3, and CHF2; R 7 Selected from one of CH3, Ph, 4-Cl-Ph; R 8 Selected from one of CH3, CH2CH3, i-C3H7, c-C3H5, Ph, 4-Cl-Ph; R 9 Selected from H, Cl; R 10 It is selected from one of H, 2-Cl, 3-Cl, 4-Cl, 2,4-Cl2, 2,4,6-Cl3, 2-F, 3-F, 4-F, 2,4-F2, 4-CH3, 4-CF3, 4-OCH3, and 4-OCF3.
[0008] When Ar is a benzene ring, it is selected from Ph, 2-Cl-Ph, 3-Cl-Ph, 4-Cl-Ph, 2,4-Cl2-Ph, 2,4,6-Cl3-Ph, 2-F-Ph, 3-F-Ph, 4-F-Ph, 2,4-F2-Ph, 4-CH3-Ph, 4-CF3-Ph, 4-OCH3-Ph, and 4-OCF3-Ph.
[0009] When Ar is a thiazole ring, it is... .
[0010] When Ar is a pyridine ring, it is selected from... One of them.
[0011] The method for preparing the cyclopropyl-containing amide compound, wherein the compound of general formula (I) is obtained from a heterocyclic carboxylic acid containing A as shown in general formula (II) and an intermediate as shown in general formula (III) via the following pathway:
[0012] In the formula, a is thionyl chloride, refluxed for 2-4 hours, or a is oxalyl chloride plus a catalytic amount of DMF, reacted for 0.5-4 hours; b is base and solvent reacted under ice-water bath conditions for 0.5 hours, then naturally heated for 2-4 hours.
[0013] The solvent is selected from one or more of dichloromethane, dichloroethane, tetrahydrofuran, and acetonitrile, and the base is selected from one or more of triethylamine, N,N-diisopropylethylamine, pyridine, sodium hydroxide, lithium hydroxide, sodium carbonate, and potassium carbonate.
[0014] The application of the cyclopropyl-containing amide compounds in inhibiting or killing harmful fungi in agricultural and horticultural pest control operations.
[0015] The harmful fungi are one or more of the following: wheat scab, tomato gray mold, rice sheath blight, tomato early blight, rice blast, and cucumber anthracnose.
[0016] The beneficial effects of this invention are as follows: This invention employs an active substructure splicing method, retaining common carboxylic acid fragments found in commercial pesticides, such as pyrazole-4-carboxylic acid, pyrazole-5-carboxylic acid, thiazole-4-carboxylic acid, thiazole-5-carboxylic acid, pyridinecarboxylic acid, benzoic acid, and phenylacetic acid; then, amine fragments containing cyclopropyl groups are introduced into the molecular structure to form novel amide derivatives containing cyclopropyl groups. These derivatives exhibit significant fungicidal (inhibitory) activity, particularly against rice sheath blight, tomato gray mold, wheat scab, and tomato early blight. The novel cyclopropyl-containing amide compound of formula (I) described in this patent has a novel molecular structure and its chemical structure has distinctive features. In this structure, A can be pyrazole, thiazole, pyridine, benzene ring, etc., and Ar can be benzene ring, pyridine ring, etc. Overall, the compound is an amide derivative. The preparation method of the compound is simple, the raw materials are readily available, the reaction conditions are easy to control, and the yield is high. The compound has significant inhibitory or killing activity against harmful agricultural fungi and can prevent and control fungal diseases of crops, and has the use as a pesticide fungicide. Detailed Implementation Example
[0017] A novel cyclopropyl-containing amide compound has the structural formula shown in formula (I): .
[0018] The preparation method of the above-mentioned cyclopropyl-containing amide compounds, wherein the compound represented by general formula (I) is obtained from a heterocyclic carboxylic acid containing A represented by general formula (II) and an intermediate represented by general formula (III) via the following pathway:
[0019] In the formula, a is thionyl chloride, refluxed for 3 h, or a is oxalyl chloride plus a catalytic amount of DMF, reacted for 2 h; b is triethylamine and dichloromethane reacted in an ice-water bath for 0.5 h and then naturally heated for 3 h.
[0020] The detailed preparation methods for some compounds are as follows: Preparation of N-(2-(4-chlorophenyl)-1-cyclopropylethyl)-N-methoxy-1,3-dimethyl-1H-pyrazole-5-carboxamide (I10): Compound (I10) was prepared by the method shown below:
[0021] The intermediate 1,3-dimethyl-pyrazole-5-carboxylic acid (Type A) reacts with thionyl chloride to prepare 1,3-dimethyl-pyrazole-5-carboxylic acid chloride. Then, it reacts with N-(2-(4-chlorophenyl)ethyl)-1-cyclopropyl-O-methoxyamine in a triethylamine-based acid-binding agent and dichloromethane-based solvent, first in an ice-water bath and then at room temperature for 4 hours to obtain product I10.
[0022] It is important to emphasize the synthesis of the intermediate N-(2-(4-chlorophenyl)ethyl)-1-cyclopropyl-O-methoxyamine: Starting with 4-chlorobenzyl chloride, it reacts with metallic magnesium to generate the corresponding Grignard reagent, which then reacts with cyclopropyl nitrile. Following hydrolysis or acidolysis, it yields 2-(4-chlorophenyl)-1-cyclopropylethan-1-one. This is then reacted with methoxyamine hydrochloride to give [2-(4-chlorophenyl)-1-cyclopropyl]ethyl-1-O-methyl oxime, which is further reduced by a specific reducing agent (such as sodium cyanoborohydride or sodium borohydride) to obtain the intermediate N-(2-(4-chlorophenyl)ethyl)-1-cyclopropyl-O-methoxyamine.
[0023]
[0024] 1 H NMR (400 MHz, CDCl3) δ 7.31 – 7.28 (m, 2H), 7.15 (d,J = 8.5 Hz,2H), 3.80 (s, 2H), 1.99 – 1.91 (m, 1H), 1.07 – 1.00 (m, 2H), 0.90 – 0.83 (m,2H). Preparation of N-(1-cyclopropyl-2-phenylethyl)-N-methoxy-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide (I376): Compound (I376) was prepared by the method shown below:
[0025] The intermediate 1-methyl-3-trifluoromethyl-pyrazole-4-carboxylic acid (Type A) reacts with thionyl chloride to prepare 1-methyl-3-trifluoromethyl-pyrazole-4-carboxyl chloride. Then, it reacts with N-(1-cyclopropyl-2-phenylethyl)-O-methoxyamine in a triethylamine-based acid-binding agent and dichloromethane-based solvent, first in an ice-water bath and then at room temperature for 4 hours to obtain product I376.
[0026]
[0027] 1 H NMR (400 MHz, CDCl3) δ 7.32 (t, J = 7.3 Hz, 2H), 7.22 (td, J =16.9, 7.5 Hz, 3H), 3.81 (s, 2H), 2.00 – 1.90 (m, 1H), 1.03 (dq, J = 7.2, 3.8Hz, 2H), 0.83 (dq, J = 7.3, 3.6 Hz, 2H). (E / Z exist simultaneously) 1 H NMR (400 MHz, CDCl3) δ 7.29 (dd, J = 11.4, 4.1 Hz, 2H), 7.19 (dd, J = 12.2, 5.2 Hz, 3H), 3.94 (s, 1H), 3.25 (s, 1H), 2.21 (tt, J = 8.6, 5.4 Hz, 1H), 0.70 (dq, J= 5.2, 3.3 Hz, 2H), 0.66 – 0.59 (m, 2H). or 1 H NMR (400 MHz, CDCl3) δ 7.29 (dd, J = 11.4, 4.1 Hz, 2H), 7.19 (dd, J = 12.2, 5.2 Hz, 3H), 3.84 (s, 1H), 3.62 (s, 1H), 1.48 – 1.39 (m, 1H), 0.70 (dq, J = 5.2, 3.3 Hz,2H), 0.66 – 0.59 (m, 2H).
[0028] 1 H NMR (400 MHz, CDCl3) δ 7.30 (ddd, J = 11.1, 7.3, 3.9 Hz, 2H), 7.22(dd, J = 11.2, 4.5 Hz, 3H), 5.88 (s, 1H), 3.64 (s, 3H), 3.02 – 2.84 (m, 2H), 2.30 (dt, J = 9.4, 6.6 Hz, 1H), 0.85 – 0.74 (m, 1H), 0.58 – 0.41 (m, 1H), 0.32 (tt, J = 12.5, 6.2 Hz, 1H), 0.05 – -0.07 (m, 1H). The NMR data of some of the prepared compounds are as follows:
[0029] N-(1-cyclopropyl-2-(2-fluorophenyl)ethyl)-N-methoxy-1,3-dimethyl-1H-pyrazole-4-carboxamide(I319) 1 H NMR (400 MHz, CDCl3) δ 7.61(s,1H), 7.24 (t, J = 7.6 Hz, 1H), 7.15 (dd, J = 13.3, 6.2 Hz, 1H), 6.98 (dd, J= 18.8, 8.7 Hz,2H), 3.86 (s, 1H), 3.83 (s, 2H), 3.69 (s, 3H), 3.22 – 3.14 (m, 2H), 2.38 (s,3H), 1.41 – 1.27 (m, 1H), 0.64 – 0.54 (m, 1H), 0.54 – 0.42 (m, 1H), 0.39 (s,1H), 0.14 (td, J = 9.7, 4.9 Hz, 1H). 19 F NMR (376 MHz, CDCl3) δ -118.12.
[0030] N-(1-cyclopropyl-2-(2-fluorophenyl)ethyl)-N-methoxy-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide(I394) 1 H NMR (400 MHz, CDCl3) δ7.61 (s, 1H), 7.30 – 7.25 (m, 1H), 7.19 (d, J = 6.4 Hz, 1H), 7.05 (d, J = 7.3Hz, 1H), 7.02 – 6.97 (m, 1H), 3.92 (s, 3H), 3.59 (s, 3H), 3.20 (d, J = 7.3Hz, 2H), 1.61 (s, 1H), 1.41 – 1.29 (m, 1H), 0.67 – 0.57 (m, 1H), 0.56 – 0.47(m, 1H), 0.42 (s, 1H), 0.16 (td, J = 9.7, 4.9 Hz, 1H). 19 F NMR (376 MHz,CDCl3) δ -61.23, -118.09.
[0031] N-(1-cyclopropyl-2-phenylethyl)-3-(difluoromethyl)-N-methoxy-1-methyl-1H-pyrazole-4-carboxamide(I457)1 H NMR (400 MHz, CDCl3) δ 7.76 (s, 1H),7.20 (t, J = 7.6 Hz, 1H),7.16(t, J = 44 Hz, 1H), 7.13 (d, J = 7.4 Hz, 1H),6.98 (dd, J = 7.9, 5.8 Hz, 2H), 3.95 (s, 3H), 3.77 (s, 1H), 3.68 (s, 3H),3.19 (d, J = 7.6 Hz, 2H), 1.39 – 1.28 (m, 1H), 0.67 – 0.58 (m, 1H), 0.56 –0.47 (m, 1H), 0.47 – 0.38 (m, 1H), 0.20 (td, J = 9.8, 5.0 Hz, 1H). 19 F NMR (376MHz, CDCl3) δ-115.99, -118.17.
[0032] 5-chloro-N-(1-cyclopropyl-2-(2-fluorophenyl)ethyl)-N-methoxy-1,3-dimethyl-1H-pyrazole-4-carboxamide(I320) 1 H NMR (400 MHz, CDCl3) δ 7.31 –7.24 (m, 1H), 7.20 – 7.14 (m, 1H), 7.04 (td, J = 7.5, 1.8 Hz, 1H), 6.99 (dd, J = 13.3, 5.0 Hz, 1H), 3.77 (dd, J = 5.7, 4.0 Hz, 3H), 3.59 (s, 3H), 3.22 (d, J = 7.3 Hz, 2H), 2.15 (d, J = 2.2 Hz, 3H), 1.76 (s, 1H), 1.39 – 1.28 (m, 1H),0.58 – 0.45 (m, 2H), 0.38 (s, 1H), 0.07 (s, 1H).19 F NMR (377 MHz, CDCl3) δ -117.84.
[0033] N-(1-cyclopropyl-2-(2-fluorophenyl)ethyl)-N-methoxy-1,3-dimethyl-1H-pyrazole-5-carboxamide(I19) 1 H NMR (400 MHz, CDCl3) δ 7.26 – 7.20 (m, 1H),7.20 – 7.14 (m, 1H), 7.02 (t, J = 7.4 Hz, 1H), 7.00 – 6.94 (m, 1H), 4.13 (s,1H), 3.74 (s, 6H), 3.17 (d, J = 7.5 Hz, 2H), 2.29 (s, 1H), 2.24 (s, 3H), 1.40– 1.30 (m, 1H), 0.72 – 0.64 (m, 1H), 0.56 (d, J = 4.7 Hz, 1H), 0.40 (s, 1H),0.26 (td, J = 9.8, 4.9 Hz, 1H). 19 F NMR (376 MHz, CDCl3) δ -118.09.
[0034] N-(1-cyclopropyl-2-(2-fluorophenyl)ethyl)-N-methoxy-2-methyl-4-(trifluoromethyl)thiazole-5-carboxamide(I707) 1 H NMR (400 MHz, CDCl3) δ 7.28– 7.16 (m, 2H), 7.07 (td, J = 7.4, 0.8 Hz, 1H), 7.04 – 6.96 (m, 1H), 3.80 (s,1H), 3.53 (s, 2H), 3.21 (dd, J= 13.2, 7.9 Hz, 2H), 2.72 (s, 3H), 1.63 (s,1H), 1.39 – 1.24 (m, 1H), 0.72 – 0.61 (m, 1H), 0.55 (tt, J = 14.0, 5.2 Hz,1H), 0.46 (s, 1H), 0.25 (s, 1H). 19 F NMR (376 MHz, CDCl3) δ -61.84, -117.94.
[0035] N-(1-cyclopropyl-2-(2-fluorophenyl)ethyl)-N-methoxy-2-phenylthiazole-4-carboxamide(I882) 1 H NMR (400 MHz, CDCl3) δ 7.86 (s, 2H), 7.48 – 7.42 (m,3H), 7.39 (s, 1H), 7.19 (d, J = 6.5 Hz, 1H), 7.09 (d, J = 5.8 Hz, 1H), 6.98(t, J = 7.3 Hz, 1H), 6.68 (s, 1H),4.41 (s, 1H), 4.01 (s, 3H), 3.15 (d, J =9.3 Hz, 2H), 1.48 – 1.35 (m, 1H), 0.83 (d, J = 23.3 Hz, 1H), 0.75 (s, 1H),0.66 (s, 1H), 0.38 (s, 1H). 19 F NMR (376 MHz, CDCl3) δ -118.69.
[0036] N-(2-(4-chlorophenyl)-1-cyclopropylethyl)-N-methoxy-1,3-dimethyl-1H-pyrazole-5-carboxamide(I10) 1 H NMR (400 MHz, CDCl3) δ 7.23 – 7.18 (m, 2H),7.12 (d, J= 7.9 Hz, 2H), 6.24 (s, 1H), 3.74 (s, 6H), 3.17 (dd, J = 13.8, 9.5Hz, 1H), 2.99 (d, J = 10.4 Hz, 1H), 2.24 (s, 3H), 1.35 – 1.22 (m, 1H), 0.75 –0.64 (m, 1H), 0.54 (d, J = 31.0 Hz, 1H), 0.44 (td, J = 10.1, 5.1 Hz, 1H),0.24 (tt, J = 20.1, 10.0 Hz, 1H).
[0037] 5-chloro-N-(2-(4-chlorophenyl)-1-cyclopropylethyl)-N-methoxy-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide(I386) 1 H NMR (400 MHz,CDCl3) δ 7.26 (t, J = 3.2 Hz, 2H), 7.24 – 7.17 (m, 2H), 3.90 (s, 3H), 3.40(s, 3H), 3.22 (dd, J = 14.0, 8.2 Hz, 1H), 3.11 (dd, J = 14.0, 7.2 Hz, 1H),1.34 – 1.24 (m, 1H), 0.58 (s, 1H), 0.55 – 0.43 (m, 1H), 0.10 (s, 1H). 19 F NMR(377 MHz, CDCl3) δ -61.90.
[0038] N-(1-cyclopropyl-2-phenylethyl)-N-methoxy-1,3-dimethyl-1H-pyrazole-5-carboxamide(I1) 1H NMR (400 MHz, CDCl3) δ 7.26 – 7.21 (m, 2H), 7.20 – 7.14(m, 3H), 6.19 (s, 1H), 3.77 (d, J = 25.6 Hz, 6H), 3.20 (dd, J = 13.8, 9.6 Hz,1H), 3.03 (s, 1H), 2.22 (s, 3H), 1.38 – 1.24 (m, 1H), 0.74 – 0.63 (m, 1H),0.58 (s, 1H), 0.42 (dd, J = 9.2, 4.7 Hz, 1H), 0.25 (td, J = 9.9, 4.9 Hz, 1H).
[0039] 2-chloro-N-(1-cyclopropyl-2-(2-fluorophenyl)ethyl)-N-methoxynicotinamide (I957) 1 H NMR (400 MHz, CDCl3) δ 8.40 (d, J =1.5Hz,1H),7.34 (dd, J = 15.3, 7.4 Hz, 2H), 7.25 – 7.19 (m, 2H), 7.10 (t, J = 7.4 Hz,1H), 7.07 – 6.88 (m, 2H), 3.43 (s, 2H), 3.28 (d, J = 7.4 Hz, 2H), 3.07 (s, 1H) , 1.70 (d, J = 8.1 Hz, 1H), 1.38 (t, J = 11.2 Hz, 1H), 0.66 (dd, J = 15.9,11.1 Hz, 2H), 0.61 – 0.51 (m, 2H). 19 F NMR (376 MHz, CDCl3) δ -117.59.
[0040] N-(1-cyclopropyl-2-(2-fluorophenyl)ethyl)-N-methoxy-4-methyl-2-phenylthiazole-5-carboxamide (I657) 1 H NMR (400 MHz, CDCl3) δ 7.97 (dd, J =6.6, 2.9 Hz, 2H), 7.47 – 7.42 (m, 3H), 7.29 – 7.22 (m, 1H), 7.15 (td, J =7.4, 1.5 Hz, 1H), 7.03 – 6.94 (m, 2H), 3.92 – 3.83 (m, 1H), 3.74 (s, 3H),3.28 – 3.14 (m, 2H), 2.66 (s, 3H), 1.39 – 1.29 (m, 1H), 0.67 (tt, J = 8.4,5.2 Hz, 1H), 0.61 – 0.52 (m, 1H), 0.51 – 0.42 (m, 1H), 0.26 (td, J = 9.8, 4.9Hz, 1H). 19 F NMR (376 MHz, CDCl3) δ -118.01.
[0041] 5-chloro-N-(1-cyclopropyl-2-(2-fluorophenyl)ethyl)-N-methoxy-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide(I395) 1 H NMR (400 MHz,CDCl3) δ 7.30 (s, 1H), 7.20 (ddd, J = 13.3, 6.3, 1.6 Hz, 1H), 7.06 (dd, J =9.4, 5.5 Hz, 1H), 7.00 (t, J = 9.1 Hz, 1H), 3.90 (s, 3H), 3.78 (s, 1H), 3.39(s, 3H), 3.25 (d, J= 7.5 Hz, 2H), 1.36 (s, 1H), 0.63 – 0.40 (m, 3H), 0.14(dd, J = 13.6, 4.2 Hz, 1H). 19 F NMR (376 MHz, CDCl3) δ -61.92,-118.04.
[0042] 5-chloro-N-(1-cyclopropyl-2-phenylethyl)-N-methoxy-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide(I377) 1 H NMR (400 MHz, CDCl3) δ7.29 – 7.23 (m, 4H), 7.19 (dd, J = 9.0, 4.4 Hz, 1H), 3.89 (s, 3H), 3.78 (s,1H), 3.33 (d, J = 23.2 Hz, 2H), 3.27 (dd, J = 13.9, 8.2 Hz, 1H), 3.15 (dd, J = 13.9, 7.3 Hz, 1H), 1.36 – 1.24 (m, 1H), 0.56 (s, 1H), 0.53 – 0.42 (m, 2H),0.09 (d, J = 10.2 Hz, 1H). 19 F NMR (377 MHz, CDCl3) δ -61.89.
[0043] 1-(4-chlorophenyl)-N-(1-cyclopropyl-2-(2-fluorophenyl)ethyl)-N-methoxy-5-(trifluoromethyl)-1H-pyrazole-4-carboxamide(I507) 1 H NMR (400 MHz,CDCl3) δ 7.69 (s, 1H), 7.49 – 7.44 (m, 2H), 7.39 (d, J= 8.4 Hz, 2H), 7.33 –7.27 (m, 1H), 7.20 (s, 1H), 7.08 (t, J = 6.9 Hz, 1H), 7.05 – 6.98 (m, 1H),3.88 (s, 1H), 3.54 (s, 3H), 3.23 (d, J = 4.7 Hz, 2H), 1.35 (tdd, J = 12.7,8.7, 3.9 Hz, 1H), 0.64 (ddd, J = 10.3, 8.6, 5.3 Hz, 1H), 0.55 (s, 1H), 0.47(s, 1H), 0.21 (s, 1H). 19 F NMR (376 MHz, CDCl3) δ -56.33,-110.61,-117.88.
[0044] N-(1-cyclopropyl-2-(2-fluorophenyl)ethyl)-N-methoxy-1-phenyl-5-(trifluoromethyl)-1H-pyrazole-4-carboxamide(I482) 1 H NMR (400 MHz, CDCl3) δ7.70 (s, 1H), 7.54 – 7.47 (m, 3H), 7.45 (s, 2H), 7.30 (t, J = 7.0 Hz, 1H),7.21 (s, 1H), 7.08 (t, J = 7.1 Hz, 1H), 7.05 – 6.98 (m, 1H), 3.72 (d, J =136.3 Hz, 3H), 3.24 (s, 2H), 1.40 – 1.30 (m, 1H), 0.91 – 0.82 (m, 1H), 0.64(ddd, J = 10.2, 8.6, 5.3 Hz, 1H), 0.52 (d, J = 21.6 Hz, 1H), 0.47 (s, 1H),0.21 (s, 1H). 19 F NMR (376 MHz, CDCl3) δ -56.23,-117.88.
[0045] N-(2-(4-chlorophenyl)-1-cyclopropylethyl)-N-methoxy-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide(I385) 1 H NMR (400 MHz, CDCl3) δ7.56 (s, 1H), 7.24 (d, J = 8.3 Hz, 2H), 7.16 (d, J = 8.4 Hz, 2H), 3.92 (s,3H), 3.57 (s, 3H), 3.19 (dd, J = 13.8, 8.8 Hz, 1H), 3.05 (s, 1H), 1.34 – 1.20(m, 1H), 0.63 (ddd, J = 10.5, 8.6, 5.3 Hz, 1H), 0.58 – 0.49 (m, 1H), 0.48 –0.39 (m, 1H), 0.15 (td, J = 9.9, 4.8 Hz, 1H). 19 F NMR (376 MHz, CDCl3) δ -61.28.
[0046] N-(2-(4-chlorophenyl)-1-cyclopropylethyl)-3-(difluoromethyl)-N-methoxy-1-methyl-1H-pyrazole-4-carboxamide(I454) 1 H NMR (400 MHz, CDCl3) δ7.72 (s, 1H), 7.22 – 7.16 (m, 2H), 7.15 (t, J = 48 Hz, 1H), 7.16 – 7.11 (m,2H), 3.95 (s, 1H), 3.68 (s, 1H), 3.17 (dd, J = 13.8, 8.7 Hz, 1H), 3.05 (dd, J= 13.8, 6.4 Hz, 1H), 1.31 – 1.19 (m, 1H), 0.69 – 0.59 (m, 1H), 0.58 – 0.47(m, 1H), 0.47 – 0.37 (m, 1H), 0.17 (td, J = 9.9, 4.9 Hz, 1H). 19 F NMR (376MHz, CDCl3) δ -115.99.
[0047] 6-chloro-N-(1-cyclopropyl-2-phenylethyl)-N-methoxynicotinamide(I1351) 1 H NMR (400 MHz, CDCl3) δ 8.36 (s, 1H), 7.62 (s, 1H), 7.38 – 7.24 (m, 3H),7.21 (d, J = 6.7 Hz, 3H), 3.59 (s, 2H), 3.22 (dd, J = 13.6, 10.4 Hz, 1H),3.08 (d, J = 7.9 Hz, 1H), 1.32 (s, 1H), 0.75 (ddd, J = 10.3, 8.6, 5.2 Hz,1H), 0.61 (s, 1H), 0.48 (s, 1H), 0.34 (s, 1H).
[0048] N-(1-cyclopropyl-2-phenylethyl)-N-methoxy-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide(I385) 1 H NMR (400 MHz, CDCl3) δ7.52 (s, 1H), 7.25 (dd, J = 19.2, 6.5 Hz, 5H), 3.86 (s, 3H), 3.58 (s, 3H),3.22 (dd, J = 13.7, 9.2 Hz, 1H), 3.05 (s, 1H), 1.35 – 1.23 (m, 1H), 0.61 (t,J = 13.1 Hz, 1H), 0.51 (d, J = 5.0 Hz, 1H), 0.42 (s, 1H), 0.17 (td, J = 9.8,4.8 Hz, 1H). 19 F NMR (376 MHz, CDCl3) δ -61.24.
[0049] N-(1-cyclopropyl-2-phenylethyl)-3-(difluoromethyl)-N-methoxy-1-methyl-1H-pyrazole-4-carboxamide(I451) 1 H NMR (400 MHz, CDCl3) δ 7.73 (s,1H), 7.25 – 7.13 (m, 5H), 7.11 (t, J = 48 Hz, 1H), 3.92 (s, 3H), 3.67 (s,3H), 3.19 (dt, J = 24.2, 12.1 Hz, 1H), 3.07 (dd, J = 13.7, 6.1 Hz, 1H), 1.28(ddd, J = 13.6, 8.4, 3.6 Hz, 1H), 0.68 – 0.58 (m, 1H), 0.56 – 0.48 (m, 1H),0.44 (td, J = 10.1, 5.2 Hz, 1H), 0.18 (td, J = 9.9, 4.8 Hz, 1H). 19 F NMR (376MHz, CDCl3) δ -115.98.
[0050] 6-chloro-N-(2-(4-chlorophenyl)-1-cyclopropylethyl)-N-methoxynicotinamide(I1354) 1 H NMR (400 MHz, CDCl3) δ 8.45 (s, 1H), 7.28 – 7.21(m, 4H), 7.18 – 7.09 (m, 2H), 3.60 (s, 3H), 3.20 (dd,J = 13.9, 10.1 Hz, 1H), 3.05 (s, 1H), 1.36 – 1.24 (m, 1H), 0.79 – 0.68 (m, 1H), 0.61 (s, 1H), 0.49(s, 1H), 0.31 (dd, J = 9.2, 4.6 Hz, 1H). N-(1-cyclopropyl-2-(2-fluorophenyl)ethyl)-N-methoxy-1,3-dimethyl-1H-pyrazole-4-carboxamide (I319), compound (I319) was prepared by the method shown below:
[0051] The intermediate 1,3-dimethyl-pyrazole-4-carboxylic acid (Type A) reacts with thionyl chloride to prepare 1,3-dimethyl-pyrazole-4-carboxylic acid chloride. Then, it reacts with N-(1-cyclopropyl-2-(2-fluorophenyl)ethyl)-O-methoxyamine in a triethylamine-based acid-binding agent and dichloromethane-based solvent, first in an ice-water bath and then at room temperature for 4 hours to obtain product I319.
[0052]
[0053] 1 H NMR (400 MHz, CDCl3) δ 7.23 – 7.15 (m, 2H), 7.10 – 6.99 (m, 2H), 3.83 (s, 3H), 3.65 (s, 3H), 1.42 (tt, J = 8.3, 5.2 Hz, 1H), 0.72 – 0.67 (m,2H), 0.63 (tdd, J = 7.5, 5.3, 2.2 Hz, 2H). 19 F NMR (376 MHz, CDCl3) δ -117.43.
[0054] 1 H NMR (400 MHz, CDCl3) δ 7.27 – 7.15 (m, 2H), 7.09 – 6.97 (m, 2H), 5.73 (s, 1H), 3.59 (s, 3H), 3.02 (dd, J = 13.5, 6.8 Hz, 1H), 2.92 (dd,J =13.4, 6.5 Hz, 1H), 2.34 – 2.22 (m, 1H), 0.86 – 0.73 (m, 1H), 0.52 – 0.44 (m,1H), 0.40 (tdd, J = 8.9, 7.3, 2.8 Hz, 1H), 0.31 – 0.18 (m, 1H), -0.06 (td, J = 9.6, 4.9 Hz, 1H). 19 F NMR (376 MHz, CDCl3) δ -117.61. Example 2: Bactericidal activity of cyclopropyl-containing amide compounds The fungicidal activity of the novel cyclopropyl-containing amide compound I of formula (I) of the present invention was determined using rice blast fungus (… Magnaporthe grisea Rice sheath blight pathogen ( Rhizoctonia solani ), tomato gray mold ( Botrytis cinerea ), wheat scab ( Fusarium graminearum ), tomato early blight pathogen ( Alternaria solani Cucumber anthrax ( Colletotrichum orbiculare The test strains were , and the inhibition rate at different concentrations such as 300 μg / mL and 50 μg / mL was determined by the mycelial growth rate method.
[0055] The specific determination method is as follows: Accurately weigh 18 mg of the target compound and dissolve it in 1 mL of DMSO to prepare a stock solution with a concentration of 18000 μg / mL. Accurately measure 0.75 mL of the stock solution using a pipette and add it to 45 mL of sterile, molten PDA medium (solvent concentration 0.55%, less than 1%). Shake thoroughly to prepare a drug-containing medium with a concentration of 300 μg / mL. Pour this medium evenly into three disposable sterile plastic petri dishes. Use a medium with an equal amount of solvent as a blank control. Use a punch (0.5 cm inner diameter) to create holes in normally growing activated colonies to collect fungal pathogens. Use an inoculation needle to inoculate the fungal discs into the center of the above-mentioned medium. Incubate at 25±1°C. 0 Incubate the culture dish upside down in a constant temperature incubator under dark conditions. When the colony diameter on the control medium reaches approximately 2 / 3 of the plate's length, measure its diameter. Measure each colony diameter twice using a cross-sectional method and calculate the average. Triple replicates are performed for each concentration and the blank control. The growth inhibition rate of the agent is calculated using the following formula: I(%) = (C - T) / (C - 0.5) × 100% In the above formula, I is the mycelial growth inhibition rate, C is the average diameter of the control colony, and T is the average diameter of the drug-treated colony.
[0056] The bactericidal activity (inhibition rate, %) of the novel cyclopropyl-containing amide compound (I) of formula (I) at a concentration of 300 μg / mL.
[0057] At a concentration of 300 μg / mL, the target compound (I) showed high inhibitory activity against all six tested fungi, with inhibition rates exceeding 90% or even higher.
[0058] The fungicidal activity of the novel cyclopropyl-containing amide compounds of formula (I) of this invention at a concentration of 50 μg / mL is shown in Table 1. Overall, the target compounds still exhibit moderate to significant fungicidal (bacteriostatic) activity. For *Rhizoctonia solani*, compounds I319, I394, I457, I707, I882, and I10 showed inhibition rates higher than 56% at the tested concentrations, but their inhibitory activity was lower than that of commercially available fungicides such as boscalid and azoxystrobin. For *Botrytis cinerea*, compounds I319, I394, I457, I707, and I882 all showed inhibitory activities higher than 55% at the tested concentrations, and all were higher than the control fungicide azoxystrobin, but slightly lower than boscalid. For *Fusarium graminearum*, compounds I394, I457, I707, and I882 all showed inhibitory activities exceeding 50% at the tested concentrations. I394 exhibited activity comparable to that of boscalid and azoxystrobin, while I882 showed higher inhibitory activity against *Fusarium graminearum* than both boscalid and azoxystrobin. For *Early blight*, at the tested concentrations, compound I320 showed inhibitory activity comparable to azoxystrobin, while compounds I319, I394, I457, and I882 showed higher inhibitory activities than azoxystrobin. Furthermore, I319 showed inhibitory activity comparable to boscalid. For *Blastomyces oryzae*, at the tested concentrations, the inhibitory activity of compound (I) was significantly lower than that of the commercially available fungicides boscalid and azoxystrobin.
[0059] Table 1 shows the bactericidal activity (inhibition rate, %) of cyclopropyl-containing amide compounds (I) of formula (I) at a concentration of 50 μg / mL.
[0060] The embodiments described above are merely illustrative of several implementations of the present invention, and while the descriptions are relatively specific and detailed, they should not be construed as limiting the scope of the invention patent. It should be noted that those skilled in the art can make various modifications and improvements without departing from the concept of the present invention, and these all fall within the protection scope of the present invention. Therefore, the protection scope of this invention patent should be determined by the appended claims.
Claims
1. An amide compound containing a cyclopropyl group, characterized in that, The structural formula of the compound is shown in formula (I). ; R is selected from CH3, C2H5, i-C3H7, c-C3H 5、 One of CH2CH(CH3)2; A is selected from one of the following rings: pyrazole, thiazole, pyridine, pyrimidine, oxazole, thiophene, benzene ring, etc.; Ar is selected from one of the following rings: benzene ring, pyridine ring, thiazole ring.
2. The cyclopropyl-containing amide compound according to claim 1, characterized in that, R is one of CH3 or CH2CH3; A is selected from one of pyrazole, pyridine, or benzene ring.
3. The cyclopropyl-containing amide compound according to claim 1, characterized in that, The A is selected from A1-A9; A1-A9 are shown below: ; Where R 1 Selected from one of CH3, C2H5, CH2=CH2, i-C3H7, c-C3H5, -CH2CF3, -CH2CH(CH3)2, -CH2CH(CH2)2, Ph, 4-Cl-Ph; R 2 Selected from one of H, CH3, C2H5, i-C3H7, c-C3H5, CF3, CHF2, -CH2CH(CH3)2, -C(CH3)3; R 3 Selected from one of H, Cl, Br; R 4 Selected from CH3 and CF3; R 5 Selected from one of OCH3 and OCH2CH3; R 6 Selected from one of CH3, CF3, and CHF2; R 7 Selected from one of CH3, Ph, 4-Cl-Ph; R 8 Selected from one of CH3, CH2CH3, i-C3H7, c-C3H5, Ph, 4-Cl-Ph; R 9 Selected from H, Cl; R 10 It is selected from one of H, 2-Cl, 3-Cl, 4-Cl, 2,4-Cl2, 2,4,6-Cl3, 2-F, 3-F, 4-F, 2,4-F2, 4-CH3, 4-CF3, 4-OCH3, and 4-OCF3.
4. The cyclopropyl-containing amide compound according to claim 1, characterized in that, When Ar is a benzene ring, it is selected from Ph, 2-Cl-Ph, 3-Cl-Ph, 4-Cl-Ph, 2,4-Cl2-Ph, 2,4,6-Cl3-Ph, 2-F-Ph, 3-F-Ph, 4-F-Ph, 2,4-F2-Ph, 4-CH3-Ph, 4-CF3-Ph, 4-OCH3-Ph, and 4-OCF3-Ph.
5. The cyclopropyl-containing amide compound according to claim 1, characterized in that, When Ar is a thiazole ring, it is... .
6. The cyclopropyl-containing amide compound according to claim 1, characterized in that, When Ar is a pyridine ring, it is selected from... One of them.
7. The method for preparing the cyclopropyl-containing amide compound according to claim 1, characterized in that, The compound represented by general formula (I) is obtained from a heterocyclic carboxylic acid containing A represented by general formula (II) and an intermediate represented by general formula (III) via the following pathway: , In the formula, a is thionyl chloride, refluxed for 2-4 hours, or a is oxalyl chloride plus a catalytic amount of DMF, reacted for 0.5-4 hours; b is base and solvent reacted under ice-water bath conditions for 0.5 hours, then naturally heated for 2-4 hours.
8. The method for preparing the cyclopropyl-containing amide compound according to claim 7, characterized in that, The solvent is selected from one or more of dichloromethane, dichloroethane, tetrahydrofuran, and acetonitrile, and the base is selected from one or more of triethylamine, N,N-diisopropylethylamine, pyridine, sodium hydroxide, lithium hydroxide, sodium carbonate, and potassium carbonate.
9. The use of the cyclopropyl-containing amide compound of claim 1 in inhibiting or killing harmful fungi in agricultural and horticultural pest control operations.
10. The application according to claim 9, characterized in that, The harmful fungi are one or more of the following: wheat scab, tomato gray mold, rice sheath blight, tomato early blight, rice blast, and cucumber anthracnose.
